A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
National Cancer Institute (NCI)
NiKang Therapeutics, Inc.
Pliant Therapeutics, Inc.
Eli Lilly and Company
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Kivu Bioscience Inc.
University of California, San Francisco
MOMA Therapeutics
Kestrel Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
AstraZeneca
Beijing Biotech
Parabilis Medicines, Inc.
Revolution Medicines, Inc.
University of Rochester
Eikon Therapeutics
USWM, LLC (dba US WorldMeds)
Rutgers, The State University of New Jersey
Conjupro Biotherapeutics, Inc.
Incyclix Bio
M.D. Anderson Cancer Center
Unidade Local de Saúde São João
National Cancer Institute (NCI)
GlaxoSmithKline
Institut Paoli-Calmettes
Orano Med LLC
Artios Pharma Ltd
GI Innovation, Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
Alterome Therapeutics, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Ascendis Pharma A/S
Pfizer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech